- [CONDYDAV: A multicentre observational study of patients presenting external genital warts in France]J Chanal
Departement de Dermatologie, CIDDIST Tarnier, Hopital Cochin, 89, rue d Assas, 75006 Paris, France Electronic address
Ann Dermatol Venereol 143:675-681. 2016..Since 2007 in France, human papilloma virus (HPV) vaccination has been licensed for use as a vaccine against HPV 6, 11, 16 and 18. The impact on the epidemiology of external genital warts (EGWs) in a large population remains unclear...
- [What's new in the diagnosis and treatment of Neisseria gonorrhoeae]Johan Chanal
Assistance Publique Hopitaux de Paris, Universite Paris 5, Hopital Cochin, Service de Dermatologie, Paris, France
Presse Med 42:454-8. 2013..gonorrhoeae infections. Screening of partners of identified cases and other STDs is the main measure to add to the treatment of gonorrhea...
- Molecular subtyping of Treponema pallidum in Paris, FrancePhilippe Alain Grange
Laboratoire de Recherche en Dermatologie, EA 1833, Centre National de Référence Syphilis, Faculte de Medecine, Université Sorbonne Paris Descartes, Paris, France
Sex Transm Dis 40:641-4. 2013..A new subtype named 11 q/j was characterized, and a reinfection case was determined in 1 patient having consecuitve syphilis infection at 19-month interval. ..
- Age and clear eyes are associated with an increased risk of cutaneous squamous cell carcinomas in vemurafenib-treated melanoma patientsFlorian Herms
aDepartment of Dermatology, Cochin Hospital bFaculty of Medicine, Paris Descartes University cDepartment of Pathology, Cochin Hospital, Paris, France
Melanoma Res 26:487-91. 2016..Clinicians should be vigilant in older patients undergoing vemurafenib therapy as well as patients with clear eyes as they seem to be at increased risk of developing cSCC, even late after the initiation of treatment. ..